Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action
Abstract
Mastiha is a natural nutritional supplement with known anti-inflammatory properties. Non-alcoholic fatty liver disease (NAFLD) and Inflammatory bowel disease (IBD) are immune mediated inflammatory diseases that share common pathophysiological features. Mastiha has shown beneficial effects in both diseases. MicroRNAs have emerged as key regulators of inflammation and their modulation by phytochemicals have been extensively studied over the last...
Paper Details
Title
Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action
Published Date
Sep 1, 2021
Journal
Volume
171
Pages
105753 - 105753
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History